Hospital-Level Variation in Practice Patterns and Patient Outcomes for Pediatric Patients Hospitalized With

Jamie Librizzi1, Samuel Flores2, Keith Morse2

  • 1Department of Pediatric Hospital Medicine, Phoenix Children's Hospital, Phoenix, Arizona; and jlibrizzi@phoenixchildrens.com.

Hospital Pediatrics
|May 20, 2017
PubMed

Insights

Hospitalized pediatric constipation management varies widely across US children's hospitals. Standardizing care with evidence-based guidelines is recommended to improve outcomes for functional constipation in children.

Area of Science:

  • Pediatric Gastroenterology
  • Hospital Medicine
  • Clinical Practice Patterns

Background:

  • Functional constipation affects 3-5% of children aged 4-17 years.
  • No current evidence-based guidelines exist for managing hospitalized pediatric constipation.
  • This study evaluates current practices and outcomes in US children's hospitals.

Purpose of the Study:

  • To assess practice variations in managing hospitalized pediatric functional constipation.
  • To analyze patient outcomes associated with current management strategies.
  • To identify areas for improvement in hospital care for pediatric constipation.

Main Methods:

  • Multicenter, retrospective cohort study (2012-2014).
  • Included children (0-18 years) hospitalized for functional constipation using ICD-9 codes.
  • Excluded patients with complex chronic conditions; analyzed therapies, length of stay, and readmission rates.

Main Results:

  • 14,243 hospitalizations analyzed; 0.65% of admissions were for functional constipation.
  • Wide variation in treatments used: electrolyte laxatives (40-96%), sodium phosphate enema (0-64%), etc.
  • Mean length of stay was 1.97 days; mean 90-day readmission rate was 3.78%.

Conclusions:

  • Significant variability exists in pediatric functional constipation management and outcomes across US hospitals.
  • Lack of standardized, evidence-based guidelines contributes to practice variation.
  • Adopting best practices could standardize care and improve outcomes for hospitalized children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
341
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
387
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
879